C. Bucelli
发表
A. Iurlo,
D. Cattaneo,
C. Bucelli,
2020,
Current Treatment Options in Oncology.
M. Breccia,
A. Iurlo,
D. Cattaneo,
2021,
Journal of clinical medicine.
M. Gobbi,
G. Gaidano,
F. Di Raimondo,
2019,
Cancer medicine.
R. Latagliata,
G. Rosti,
S. Russo,
2019,
Annals of Hematology.
F. Passamonti,
M. Maffioli,
L. Antolini,
2020,
Blood research.
A. Iurlo,
R. Pasquale,
D. Cattaneo,
2022,
Frontiers in Oncology.
U. Gianelli,
A. Iurlo,
B. Martino,
2022,
Cancers.
R. Latagliata,
D. Cilloni,
C. Gambacorti-Passerini,
2022,
British journal of haematology.
U. Gianelli,
I. Cortinovis,
A. Iurlo,
2017,
Histopathology.
L. Baldini,
A. Neri,
U. Gianelli,
2022,
Thrombosis research.
D. Consonni,
A. Iurlo,
D. Cattaneo,
2021,
Blood Cancer Journal.
S. Guerneri,
A. Iurlo,
D. Cattaneo,
2015,
Cytogenetic and Genome Research.
R. Latagliata,
G. Rosti,
A. Guarini,
2021,
Acta oncologica.
R. Fanin,
F. Gherlinzoni,
G. Pizzolo,
2018,
Oncotarget.
Federica,
R. Latagliata,
G. Rosti,
2022
.
A. Cortelezzi,
U. Gianelli,
E. Fermo,
2014,
Haematologica.
Low‐dose ponatinib is a good option in chronic myeloid leukemia patients intolerant to previous TKIs
G. Caocci,
M. Breccia,
L. Luciano,
2020,
American journal of hematology.
M. Griesshammer,
T. Barbui,
A. Patriarca,
2022,
American journal of hematology.
T. Barbui,
G. Tognoni,
A. Patriarca,
2021,
The Lancet. Haematology.
D. Consonni,
L. Baldini,
M. Cappellini,
2019,
American journal of hematology.
L. Baldini,
N. Fracchiolla,
A. Iurlo,
2020,
Leukemia.
L. Baldini,
A. Iurlo,
D. Cattaneo,
2020,
International journal of molecular sciences.
A. Cortelezzi,
A. Iurlo,
N. Orofino,
2016,
BioDrugs.
D. Consonni,
E. Orsi,
A. Cortelezzi,
2015,
Oncotarget.
S. Soverini,
A. Iurlo,
D. Cattaneo,
2017,
Case reports in hematology.
L. Baldini,
G. Croci,
P. Bianchi,
2021,
Frontiers in Oncology.
E. Sabattini,
L. Baldini,
P. Bianchi,
2019,
Hematological oncology.
M. Baccarani,
R. Latagliata,
G. Rosti,
2017,
Annals of Hematology.
C. Patrono,
A. Vannucchi,
A. Tosetto,
2021,
Clinical pharmacology and therapeutics.
C. Patrono,
A. Vannucchi,
A. Tosetto,
2020,
Blood.
D. Mari,
A. Cortelezzi,
A. Iurlo,
2014,
European journal of internal medicine.
A. Terrasi,
C. Augello,
I. Martinelli,
2016,
Annals of Hematology.
U. Gianelli,
A. Iurlo,
D. Cattaneo,
2019,
Chemotherapy.
T. Barbui,
G. Tognoni,
A. Patriarca,
2022,
Blood.
A. Bosi,
R. Danesi,
G. Saglio,
2017,
Oncotarget.
R. Latagliata,
G. Rosti,
P. Vigneri,
2016,
Oncotarget.
M. Gobbi,
G. Gaidano,
F. Di Raimondo,
2019,
Cancer medicine.
M. Breccia,
A. Iurlo,
N. Orofino,
2018,
Clinical Drug Investigation.
N. Bolli,
D. Consonni,
L. Baldini,
2023,
Annals of Hematology.
D. Consonni,
A. Iurlo,
D. Cattaneo,
2022,
British journal of haematology.
B. Di Camillo,
R. Cairoli,
G. Rossi,
2019,
PloS one.
D. Consonni,
A. Iurlo,
D. Cattaneo,
2023,
British journal of haematology.
D. Consonni,
C. Augello,
S. Bosari,
2015,
British journal of haematology.
G. Pravettoni,
S. Riva,
E. Orlandi,
2022,
Patient preference and adherence.
T. Barbui,
G. Tognoni,
A. Patriarca,
2023,
NEJM Evidence.
A. Iurlo,
D. Cattaneo,
C. Bucelli,
2023,
Current Treatment Options in Oncology.
R. Foà,
R. Latagliata,
G. Saglio,
2023,
Frontiers in Pharmacology.
R. Foà,
R. Fanin,
R. Latagliata,
2023,
Cancer.
A. Cortelezzi,
A. Iurlo,
N. Orofino,
2016,
BioDrugs.
U. Gianelli,
A. Iurlo,
D. Cattaneo,
2022,
Frontiers in Oncology.
L. Baldini,
A. Iurlo,
W. Barcellini,
2021,
Frontiers in Oncology.
G. Pravettoni,
S. Riva,
E. Orlandi,
2022
.
A. Cortelezzi,
U. Gianelli,
N. Fracchiolla,
2017,
Leukemia research reports.
B. Druker,
M. Maffioli,
L. Busque,
2023,
American journal of hematology.
L. Baldini,
A. Neri,
N. Fracchiolla,
2020,
Blood Advances.
A. Iurlo,
D. Cattaneo,
C. Bucelli,
2023,
Current treatment options in oncology.
U. Gianelli,
A. Iurlo,
D. Cattaneo,
2023,
Leukemia research.
M. Griesshammer,
T. Barbui,
A. Patriarca,
2022,
Blood Cancer Journal.
A. Vannucchi,
A. Tosetto,
N. Vianelli,
2024,
American journal of hematology.
N. Bolli,
A. Iurlo,
D. Cattaneo,
2024,
Clinical and experimental medicine.
N. Fracchiolla,
A. Iurlo,
D. Cattaneo,
2024,
Current hematologic malignancy reports.